Whitepaper: Monitoring a pharmaceutical crystal transformation in situ
Many organic compounds can crystallize in several different forms called polymorphs. Biologically active polymorphs have different solubility and stability and, hence, different bioavailability. The effectiveness of a drug compound depends critically on its particular polymorph.
There are two types of polymorphic systems: monotropic and enantiotropic. In monotropic systems, one polymorph is more stable than the other at all temperatures below the melting point. In enantiotropic systems, one polymorph is more stable than the other above a certain temperature and the other polymorph is more stable below this temperature. In addition, some systems include hydrates and solvates. Hydrates include water in the crystal lattice and solvates include other solvent molecules. Hydrates and solvates are not true polymorphs because they differ by more than just the three-dimensional arrangement of the crystal lattice, but they occur along with polymorphs in real systems and are important to consider in the same context.
Related content from this organisation
- Application Notes & Whitepapers 2017
- Application note: Representative sampling in process Raman spectroscopy
- Whitepaper: Downstream biopharmaceutical operations
- Whitepaper: Raman-Based Nutrient Control in Bioprocessing Optimises Viable Cell Density and Protein Glycation
- Whitepaper: Raman-Based Endpoint Detection of a Heterogeneous Etherification Reaction